- Drug Class
- Antiplatelet (COX Inhibitor)
- Mechanism of Action (MOA)
- Irreversibly acetylates COX-1 → ↓ thromboxane A2 → impaired platelet aggregation for the platelet's life (~7–10 days).
- Clinical Notes
- ACS and secondary prevention. GI bleeding; Reye syndrome in children with viral illness; tinnitus in salicylate overdose.
Sources
Reviewed September 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
All pharmacology